Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors

In B-chronic lymphocytic leukemia (B-CLL), the interaction between leukemic cells and the microenvironment promotes tumor cell survival. The Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib is one of the first-in-class molecules for the treatment of B-CLL patients; however, the emerging mechanisms...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Oncol
Autors principals: Rimondi, Erika, Melloni, Elisabetta, Romani, Arianna, Tisato, Veronica, Casciano, Fabio, Rigolin, Gian Matteo, Milani, Daniela, Celeghini, Claudio, Zauli, Giorgio, Secchiero, Paola, Voltan, Rebecca
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8293193/
https://ncbi.nlm.nih.gov/pubmed/34287267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28040223
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars